Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.

Novi G, Bovis F, Capobianco M, Frau J, Mataluni G, Curti E, Zuliani L, Cavalla P, Brambilla L, Annovazzi P, Repice AM, Lanzillo R, Esposito S, Benedetti L, Maietta I, Sica F, Buttari F, Malucchi S, Fenu G, Landi D, Bosa C, Realmuto S, Malentacchi M, Granella F, Signori A, Bonavita S, Uccelli A, Sormani MP; iMUST group.

Mult Scler Relat Disord. 2019 Oct 4;36:101430. doi: 10.1016/j.msard.2019.101430. [Epub ahead of print]

PMID:
31610404
2.

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.

Zecca C, Bovis F, Novi G, Capobianco M, Lanzillo R, Frau J, Repice AM, Hakiki B, Realmuto S, Bonavita S, Curti E, Brambilla L, Mataluni G, Cavalla P, Di Sapio A, Signoriello E, Barone S, Maniscalco GT, Maietta I, Maraffi I, Boffa G, Malucchi S, Nozzolillo A, Coghe G, Mechi C, Salemi G, Gallo A, Sacco R, Cellerino M, Malentacchi M, De Angelis M, Lorefice L, Magnani E, Prestipino E, Sperli F, Brescia Morra V, Fenu G, Barilaro A, Abbadessa G, Signori A, Granella F, Amato MP, Uccelli A, Gobbi C, Sormani MP.

Mult Scler. 2019 Oct 1:1352458519872889. doi: 10.1177/1352458519872889. [Epub ahead of print]

PMID:
31573386
3.

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study.

Frau J, Saccà F, Signori A, Baroncini D, Fenu G, Annovazzi P, Capobianco M, Signoriello E, Laroni A, La Gioia S, Sartori A, Maniscalco GT, Bonavita S, Clerico M, Russo CV, Gallo A, Lapucci C, Carotenuto A, Sormani MP, Cocco E; i-MuST study group.

J Neurol. 2019 Oct;266(10):2440-2446. doi: 10.1007/s00415-019-09424-8. Epub 2019 Jun 17.

PMID:
31209573
4.

An early evaluation of translocation actions for endangered plant species on Mediterranean islands.

Fenu G, Bacchetta G, Charalambos SC, Fournaraki C, Giusso Del Galdo GP, Gotsiou P, Kyratzis A, Piazza C, Vicens M, Pinna MS, de Montmollin B.

Plant Divers. 2019 Mar 21;41(2):94-104. doi: 10.1016/j.pld.2019.03.001. eCollection 2019 Apr.

5.

Is vegetation an indicator for evaluating the impact of tourism on the conservation status of Mediterranean coastal dunes?

Pinna MS, Bacchetta G, Cogoni D, Fenu G.

Sci Total Environ. 2019 Jul 15;674:255-263. doi: 10.1016/j.scitotenv.2019.04.120. Epub 2019 Apr 10.

PMID:
31004901
6.

Phylogenetically informed spatial planning as a tool to prioritise areas for threatened plant conservation within a Mediterranean biodiversity hotspot.

Carta A, Gargano D, Rossi G, Bacchetta G, Fenu G, Montagnani C, Abeli T, Peruzzi L, Orsenigo S.

Sci Total Environ. 2019 May 15;665:1046-1052. doi: 10.1016/j.scitotenv.2019.02.127. Epub 2019 Feb 11.

PMID:
30893736
7.

Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis.

Frau J, Coghe G, Lorefice L, Fenu G, Musu L, Cocco E.

J Neurol. 2019 Jun;266(6):1405-1411. doi: 10.1007/s00415-019-09272-6. Epub 2019 Mar 12.

PMID:
30863891
8.

Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy.

Lorefice L, Murgia F, Fenu G, Frau J, Coghe G, Murru MR, Tranquilli S, Visconti A, Marrosu MG, Atzori L, Cocco E.

Neurotherapeutics. 2019 Jul;16(3):797-807. doi: 10.1007/s13311-019-00721-8.

PMID:
30820880
9.

Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey.

Lavorgna L, Esposito S, Lanzillo R, Sparaco M, Ippolito D, Cocco E, Fenu G, Borriello G, De Mercanti S, Frau J, Capuano R, Trojsi F, Rosa L, Clerico M, Laroni A, Morra VB, Tedeschi G, Bonavita S.

J Neurol. 2019 Mar;266(3):707-716. doi: 10.1007/s00415-019-09193-4. Epub 2019 Jan 16.

PMID:
30649617
10.

Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers.

Fenu G, Fronza M, Lorefice L, Arru M, Coghe G, Frau J, Marrosu MG, Cocco E.

BMC Neurol. 2018 Dec 19;18(1):212. doi: 10.1186/s12883-018-1224-z.

11.

Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: A case- control MRI study.

Lorefice L, Frau J, Coghe G, Pitzalis R, Gessa I, Contu F, Barracciu MA, Marrosu MG, Cocco E, Fenu G.

Mult Scler Relat Disord. 2019 Jan;27:74-78. doi: 10.1016/j.msard.2018.10.011. Epub 2018 Oct 16.

PMID:
30343253
12.

Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score.

Coghe G, Pau M, Mamusa E, Pisano C, Corona F, Pilloni G, Porta M, Marrosu G, Vannelli A, Frau J, Lorefice L, Fenu G, Marrosu MG, Cocco E.

Disabil Rehabil. 2018 Oct 18:1-6. doi: 10.1080/09638288.2018.1506946. [Epub ahead of print]

PMID:
30334469
13.

Association between brain atrophy and cognitive motor interference in multiple sclerosis.

Coghe G, Fenu G, Lorefice L, Zucca E, Porta M, Pilloni G, Corona F, Frau J, Giovanna Marrosu M, Pau M, Cocco E.

Mult Scler Relat Disord. 2018 Oct;25:208-211. doi: 10.1016/j.msard.2018.07.045. Epub 2018 Jul 31.

PMID:
30103173
14.

Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.

Saccà F, Lanzillo R, Signori A, Maniscalco GT, Signoriello E, Lo Fermo S, Repice A, Annovazzi P, Baroncini D, Clerico M, Binello E, Cerqua R, Mataluni G, Bonavita S, Lavorgna L, Zarbo IR, Laroni A, Rossi S, Pareja Gutierrez L, La Gioia S, Frigeni B, Barcella V, Frau J, Cocco E, Fenu G, Torri Clerici V, Sartori A, Rasia S, Cordioli C, Di Sapio A, Pontecorvo S, Grasso R, Barrilà C, Russo CV, Esposito S, Ippolito D, Bovis F, Gallo F, Sormani MP.

Mult Scler. 2019 Aug;25(9):1263-1272. doi: 10.1177/1352458518790390. Epub 2018 Jul 25.

PMID:
30044207
15.

Measuring Airway Obstruction in Severe Asthma in Children.

Calogero C, Fenu G, Lombardi E.

Front Pediatr. 2018 Jun 26;6:189. doi: 10.3389/fped.2018.00189. eCollection 2018. Review.

16.

Estimating land market values from real estate offers: A replicable method in support of biodiversity conservation strategies.

Fois M, Fenu G, Bacchetta G.

Ambio. 2019 Mar;48(3):313-323. doi: 10.1007/s13280-018-1074-3. Epub 2018 Jul 10.

PMID:
29992505
17.

Interrupter resistance to measure dose-response to salbutamol in wheezy preschool children.

Beydon N, Nguyen TT, Amsallem F, Denjean A, Fenu G, Seddon P, Mentré F, Alberti C, Lombardi E.

Pediatr Pulmonol. 2018 Sep;53(9):1252-1259. doi: 10.1002/ppul.24116. Epub 2018 Jul 3.

PMID:
29972634
18.

Clinical activity after fingolimod cessation: disease reactivation or rebound?

Frau J, Sormani MP, Signori A, Realmuto S, Baroncini D, Annovazzi P, Signoriello E, Maniscalco GT, La Gioia S, Cordioli C, Frigeni B, Rasia S, Fenu G, Grasso R, Sartori A, Lanzillo R, Stromillo ML, Rossi S, Forci B, Cocco E; i-MuST study group.

Eur J Neurol. 2018 Oct;25(10):1270-1275. doi: 10.1111/ene.13694. Epub 2018 Jul 10.

PMID:
29851435
19.

Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study.

Fenu G, Arru M, Lorefice L, Frau J, Coghe G, Fronza M, Loi L, Barracciu MA, Marrosu MG, Cocco E.

Mult Scler Relat Disord. 2018 Jul;23:83-87. doi: 10.1016/j.msard.2018.05.012. Epub 2018 May 16.

PMID:
29800885
20.

A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controls.

Frau J, Fenu G, Signori A, Coghe G, Lorefice L, Barracciu MA, Sechi V, Cabras F, Badas M, Marrosu MG, Cocco E.

BMC Neurol. 2018 May 11;18(1):67. doi: 10.1186/s12883-018-1065-9.

21.

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab.

Frau J, Coghe G, Lorefice L, Fenu G, Cocco E.

Neuropsychiatr Dis Treat. 2018 Apr 23;14:1093-1099. doi: 10.2147/NDT.S147874. eCollection 2018. Review.

22.

Quality of images with toric intraocular lenses.

Tognetto D, Perrotta AA, Bauci F, Rinaldi S, Antonuccio M, Pellegrino FA, Fenu G, Stamatelatos G, Alpins N.

J Cataract Refract Surg. 2018 Mar;44(3):376-381. doi: 10.1016/j.jcrs.2017.10.053. Erratum in: J Cataract Refract Surg. 2018 Jun;44(6):794.

PMID:
29703290
23.

Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: a monocentre assessment.

Frau J, Coghe G, Casanova P, Sardu C, Lorefice L, Fenu G, Marrosu MG, Cocco E.

Eur J Neurol. 2018 Aug;25(8):1063-1068. doi: 10.1111/ene.13650. Epub 2018 Apr 25.

PMID:
29611885
24.

The impact of climatic variations on the reproductive success of Gentiana lutea L. in a Mediterranean mountain area.

Cuena-Lombraña A, Fois M, Fenu G, Cogoni D, Bacchetta G.

Int J Biometeorol. 2018 Jul;62(7):1283-1295. doi: 10.1007/s00484-018-1533-3. Epub 2018 Mar 30.

PMID:
29602965
25.

Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial.

Coghe G, Corona F, Marongiu E, Fenu G, Frau J, Lorefice L, Crisafulli A, Galli M, Concu A, Marrosu MG, Pau M, Cocco E.

J Neurol. 2018 Jun;265(6):1328-1333. doi: 10.1007/s00415-018-8836-5. Epub 2018 Mar 24.

PMID:
29574556
26.

Adult brain volume in multiple sclerosis: The impact of paediatric onset.

Fenu G, Lorefice L, Loi L, Sechi V, Contu F, Coghe G, Frau J, Spinicci G, Barracciu MA, Marrosu MG, Cocco E.

Mult Scler Relat Disord. 2018 Apr;21:103-107. doi: 10.1016/j.msard.2018.03.004. Epub 2018 Mar 6.

PMID:
29544192
27.

Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI study.

Lorefice L, Fenu G, Pitzalis R, Scalas G, Frau J, Coghe G, Musu L, Sechi V, Barracciu MA, Marrosu MG, Cocco E.

J Neurol. 2018 May;265(5):1096-1101. doi: 10.1007/s00415-018-8811-1. Epub 2018 Mar 5.

PMID:
29508133
28.

Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test.

Coghe G, Pilloni G, Zucca E, Porta M, Corona F, Frau J, Fenu G, Lorefice L, Marrosu MG, Pau M, Cocco E.

Mult Scler Relat Disord. 2018 May;22:8-11. doi: 10.1016/j.msard.2018.02.026. Epub 2018 Feb 24.

PMID:
29501850
29.

Cognition in multiple sclerosis: Between cognitive reserve and brain volume.

Fenu G, Lorefice L, Arru M, Sechi V, Loi L, Contu F, Cabras F, Coghe G, Frau J, Fronza M, Sbrescia G, Lai V, Boi M, Mallus S, Murru S, Porcu A, Barracciu MA, Marrosu MG, Cocco E.

J Neurol Sci. 2018 Mar 15;386:19-22. doi: 10.1016/j.jns.2018.01.011. Epub 2018 Jan 10.

PMID:
29406960
30.

The impact of visible and invisible symptoms on employment status, work and social functioning in Multiple Sclerosis.

Lorefice L, Fenu G, Frau J, Coghe G, Marrosu MG, Cocco E.

Work. 2018;60(2):263-270. doi: 10.3233/WOR-182682.

PMID:
29400690
31.

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.

Baroncini D, Zaffaroni M, Moiola L, Lorefice L, Fenu G, Iaffaldano P, Simone M, Fanelli F, Patti F, D'Amico E, Capobianco M, Bertolotto A, Gallo P, Margoni M, Miante S, Milani N, Amato MP, Righini I, Bellantonio P, Scandellari C, Costantino G, Scarpini E, Bergamaschi R, Mallucci G, Comi G, Ghezzi A.

Mult Scler. 2019 Mar;25(3):399-407. doi: 10.1177/1352458518754364. Epub 2018 Jan 24. Erratum in: Mult Scler. 2019 Oct;25(11):NP33.

PMID:
29363396
32.

Pulse steroid therapy in multiple sclerosis and mood changes: An exploratory prospective study.

Lorefice L, Fenu G, Fois M, Frau J, Coghe G, Marrosu MG, Cocco E.

Mult Scler Relat Disord. 2018 Feb;20:104-108. doi: 10.1016/j.msard.2018.01.012. Epub 2018 Jan 31.

PMID:
29360061
33.

Connectivity analysis of ecological landscape networks by cut node ranking.

Fenu G, Pau PL.

Appl Netw Sci. 2018;3(1):22. doi: 10.1007/s41109-018-0085-0. Epub 2018 Jul 31.

34.

Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?

Frau J, Villar LM, Sardu C, Secci MA, Schirru L, Ferraro D, Coghe G, Lorefice L, Fenu G, Bedin R, Sola P, Marrosu MG, Cocco E.

J Neurol. 2018 Feb;265(2):424-430. doi: 10.1007/s00415-017-8716-4. Epub 2017 Dec 22.

PMID:
29273846
35.

Long-term follow-up more than 10 years after HSCT: a monocentric experience.

Frau J, Carai M, Coghe G, Fenu G, Lorefice L, La Nasa G, Mamusa E, Vacca A, Marrosu MG, Cocco E.

J Neurol. 2018 Feb;265(2):410-416. doi: 10.1007/s00415-017-8718-2. Epub 2017 Dec 21.

PMID:
29270686
36.

PML in a person with multiple sclerosis: Is teriflunomide the felon?

Lorefice L, Fenu G, Gerevini S, Frau J, Coghe G, Barracciu MA, Contu F, Marrosu MG, Cocco E.

Neurology. 2018 Jan 9;90(2):83-85. doi: 10.1212/WNL.0000000000004804. Epub 2017 Dec 6. No abstract available.

PMID:
29212829
37.

Brain volume in early MS patients with and without IgG oligoclonal bands in CSF.

Fenu G, Lorefice L, Sechi V, Loi L, Contu F, Cabras F, Coghe G, Frau J, Secci MA, Melis C, Schirru L, Costa G, Melas V, Arru M, Barracciu MA, Marrosu MG, Cocco E.

Mult Scler Relat Disord. 2018 Jan;19:55-58. doi: 10.1016/j.msard.2017.11.005. Epub 2017 Nov 8.

PMID:
29132035
38.

Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy.

Lorefice L, Fenu G, Sardu C, Frau J, Coghe G, Costa G, Schirru L, Secci MA, Sechi V, Barracciu MA, Marrosu MG, Cocco E.

Mult Scler. 2019 Jan;25(1):23-30. doi: 10.1177/1352458517739989. Epub 2017 Nov 7.

PMID:
29111883
39.

Rescue therapy with alemtuzumab in multiple sclerosis post-natalizumab puerperium reactivation.

Frau J, Coghe G, Fenu G, Lorefice L, Cocco E.

Neurol Sci. 2018 Feb;39(2):389-390. doi: 10.1007/s10072-017-3135-y. Epub 2017 Oct 7. No abstract available.

PMID:
28986705
40.

'Timed up and go' and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis.

Lorefice L, Coghe G, Fenu G, Porta M, Pilloni G, Frau J, Corona F, Sechi V, Barracciu MA, Marrosu MG, Pau M, Cocco E.

J Neurol. 2017 Nov;264(11):2201-2204. doi: 10.1007/s00415-017-8612-y. Epub 2017 Sep 11.

PMID:
28894919
41.

Local shifts in floral biotic interactions in habitat edges and their effect on quantity and quality of plant offspring.

Gargano D, Fenu G, Bernardo L.

AoB Plants. 2017 Jul 26;9(4):plx031. doi: 10.1093/aobpla/plx031. eCollection 2017 Jul.

42.

Disentangling the influence of environmental and anthropogenic factors on the distribution of endemic vascular plants in Sardinia.

Fois M, Fenu G, Cañadas EM, Bacchetta G.

PLoS One. 2017 Aug 2;12(8):e0182539. doi: 10.1371/journal.pone.0182539. eCollection 2017.

43.

Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection.

Coghe G, Atzori L, Frau J, Fenu G, Lorefice L, Marrosu MG, Cocco E.

Mult Scler. 2018 Feb;24(2):231-233. doi: 10.1177/1352458517708465. Epub 2017 Jul 28.

PMID:
28752785
44.

The burden of multiple sclerosis and patients' coping strategies.

Lorefice L, Fenu G, Frau J, Coghe G, Marrosu MG, Cocco E.

BMJ Support Palliat Care. 2018 Mar;8(1):38-40. doi: 10.1136/bmjspcare-2017-001324. Epub 2017 Jun 24.

PMID:
28647714
45.

Overexpression of the Cytokine BAFF and Autoimmunity Risk.

Steri M, Orrù V, Idda ML, Pitzalis M, Pala M, Zara I, Sidore C, Faà V, Floris M, Deiana M, Asunis I, Porcu E, Mulas A, Piras MG, Lobina M, Lai S, Marongiu M, Serra V, Marongiu M, Sole G, Busonero F, Maschio A, Cusano R, Cuccuru G, Deidda F, Poddie F, Farina G, Dei M, Virdis F, Olla S, Satta MA, Pani M, Delitala A, Cocco E, Frau J, Coghe G, Lorefice L, Fenu G, Ferrigno P, Ban M, Barizzone N, Leone M, Guerini FR, Piga M, Firinu D, Kockum I, Lima Bomfim I, Olsson T, Alfredsson L, Suarez A, Carreira PE, Castillo-Palma MJ, Marcus JH, Congia M, Angius A, Melis M, Gonzalez A, Alarcón Riquelme ME, da Silva BM, Marchini M, Danieli MG, Del Giacco S, Mathieu A, Pani A, Montgomery SB, Rosati G, Hillert J, Sawcer S, D'Alfonso S, Todd JA, Novembre J, Abecasis GR, Whalen MB, Marrosu MG, Meloni A, Sanna S, Gorospe M, Schlessinger D, Fiorillo E, Zoledziewska M, Cucca F.

N Engl J Med. 2017 Apr 27;376(17):1615-1626. doi: 10.1056/NEJMoa1610528.

46.

Erratum to: Charcot-Marie-Tooth disease: genetic subtypes in the Sardinian population.

Lorefice L, Murru MR, Coghe G, Fenu G, Corongiu D, Frau J, Tranquilli S, Tacconi P, Vannelli A, Marrosu G, Mamusa E, Cocco E, Marrosu MG.

Neurol Sci. 2017 Jun;38(6):1027. doi: 10.1007/s10072-017-2944-3. No abstract available.

PMID:
28389936
47.

Charcot-Marie-Tooth disease: genetic subtypes in the Sardinian population.

Lorefice L, Murru MR, Coghe G, Fenu G, Corongiu D, Frau J, Tranquilli S, Tacconi P, Vannelli A, Marrosu G, Mamusa E, Cocco E, Marrosu MG.

Neurol Sci. 2017 Jun;38(6):1019-1025. doi: 10.1007/s10072-017-2905-x. Epub 2017 Mar 13. Erratum in: Neurol Sci. 2017 Jun;38(6):1027.

PMID:
28286897
48.

Functional models and extending strategies for ecological networks.

Fenu G, Pau PL, Dessì D.

Appl Netw Sci. 2017;2(1):10. doi: 10.1007/s41109-017-0032-5. Epub 2017 May 25.

49.

Reconsidering alternative transportation systems to reach academic conferences and to convey an example to reduce greenhouse gas emissions.

Fois M, Cuena-Lombraña A, Fristoe T, Fenu G, Bacchetta G.

Hist Philos Life Sci. 2016 Dec;38(4):25. doi: 10.1007/s40656-016-0126-x. Epub 2016 Dec 9.

PMID:
27943119
50.

Phylogeography of Arenaria balearica L. (Caryophyllaceae): evolutionary history of a disjunct endemic from the Western Mediterranean continental islands.

Bobo-Pinilla J, Barrios de León SB, Seguí Colomar J, Fenu G, Bacchetta G, Peñas de Giles J, Martínez-Ortega MM.

PeerJ. 2016 Nov 3;4:e2618. eCollection 2016.

Supplemental Content

Support Center